Literature DB >> 10337943

Acquired factor VIII inhibitor in a non-hemophilic patient with chronic hepatitis C viral infection.

K Sugishita1, H Nagase, T Takahashi, K Takenaka, Y Shiratori, M Omata.   

Abstract

Production of coagulation factor VIII inhibitor is rarely encountered in non-hemophilic patients. A 63-year-old Japanese male suffered from severe bleeding tendency caused by this inhibitor. Although he did not have malignancy or collagen disease, he had chronic hepatitis C virus (HCV) infection. Although HCV is known to induce production of various autoimmune antibodies, this may be the first report of a case with both acquired factor VIII inhibitor and HCV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337943     DOI: 10.2169/internalmedicine.38.283

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  Hepatitis C treatment with triple therapy in a patient with hemophilia A.

Authors:  Gurshawn Singh; Reuben Sass; Rayan Alamiry; Nizar Zein; Naim Alkhouri
Journal:  World J Clin Cases       Date:  2013-06-16       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.